Trials / Completed
CompletedNCT03900104
Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer
Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer: A Prospective Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Kocaeli University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The investigators think that trans-cervical endometrial tracer injection will cause more paraaortic sentinel lymph node detection. Also, this application is easy, cost-effective and safer than hysteroscopic method. Transtubal tumor spearing will not occur with this method.
Detailed description
Endometrial tracer injection will be performed by cervical or transcervical endometrial methods. Pelvic and para-aortic sentinel lymph node detection capacity will be assessed in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transcervical endometrial injection of technetium 99 m-labeled human albumin colloid particles | Transcervical endometrial injection of technetium 99 m-labeled human albumin colloid particles, in 5 mL saline, 2 hours before surgery. Injection performed with a trans-cervical catheter |
| PROCEDURE | Cervical injection of technetium 99 m-labeled human albumin colloid particles | Cervical injection of technetium 99 m-labeled human albumin colloid particles, in 5 mL saline, 2 hours before surgery. |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2020-01-01
- Completion
- 2020-01-15
- First posted
- 2019-04-02
- Last updated
- 2020-02-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03900104. Inclusion in this directory is not an endorsement.